Godamed®
For the prevention of platelet aggregation
Ingredient: Acetylsalicylic acid
Available as: tablets
Treatment area: Cardiology: antithrombotic e.g. stroke patients
Package size: 30 / 100 tablets
Approval: 1997
Shelf life: 3 years
Climate zones: II
Indication: Platelet aggregation inhibition is indicated in: unstable angina pectoris, acute mycardial infarction, re-infarction prophylaxis, after arterial surgery, prevention of transient ischamic attacks / TIA) and cerebral infarctions after precursor stages have occured
Advantegeous buffered formulation (contains glycine); different options for intake: swallow whole unchewed, with liquid or suck or chew
Other products
What we do
Our recipe for making perfect products involves three main ingredients: advanced production systems, production in Germany, and a strong commitment to quality.
